surmount-1 trial tirzepatide obesity without diabetes weight loss for maintenance of bodyweight reduction in people with in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled SURMOUNT-MMO: First trial on tirzepatide
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26






















![Osp[rey: Britannia AD 43 [2020] paperback Condition:New](https://cdn.shopify.com/s/files/1/0616/4001/6057/files/osp-rey-noon-steve-illustrator-osp-rey-britannia-ad-43-2020-paperback-9781472842077-60409555550547.jpg?v=1734155950)